168 related articles for article (PubMed ID: 23254902)
1. Anti-glomerular basement membrane antibody disease is an uncommon cause of end-stage renal disease.
Tang W; McDonald SP; Hawley CM; Badve SV; Boudville NC; Brown FG; Clayton PA; Campbell SB; de Zoysa JR; Johnson DW
Kidney Int; 2013 Mar; 83(3):503-10. PubMed ID: 23254902
[TBL] [Abstract][Full Text] [Related]
2. Predictors of renal and patient outcomes in anti-GBM disease: clinicopathologic analysis of a two-centre cohort.
Alchi B; Griffiths M; Sivalingam M; Jayne D; Farrington K
Nephrol Dial Transplant; 2015 May; 30(5):814-21. PubMed ID: 25609740
[TBL] [Abstract][Full Text] [Related]
3. Clinical features and outcomes of anti-glomerular basement membrane disease in older patients.
Cui Z; Zhao J; Jia XY; Zhu SN; Zhao MH
Am J Kidney Dis; 2011 Apr; 57(4):575-82. PubMed ID: 21168945
[TBL] [Abstract][Full Text] [Related]
4. End-Stage Kidney Disease Due to Fibrillary Glomerulonephritis and Immunotactoid Glomerulopathy - Outcomes in 66 Consecutive ANZDATA Registry Cases.
Mallett A; Tang W; Hart G; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Campbell SB; Clayton PA; Johnson DW
Am J Nephrol; 2015; 42(3):177-84. PubMed ID: 26418732
[TBL] [Abstract][Full Text] [Related]
5. End-stage renal failure due to amyloidosis: outcomes in 490 ANZDATA registry cases.
Tang W; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Clayton PA; Campbell SB; de Zoysa JR; Johnson DW
Nephrol Dial Transplant; 2013 Feb; 28(2):455-61. PubMed ID: 23182810
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes of end-stage kidney disease for patients with lupus nephritis.
Zhang L; Lee G; Liu X; Pascoe EM; Badve SV; Boudville NC; Clayton PA; Hawley CM; Kanellis J; McDonald SP; Peh CA; Polkinghorne KR; Johnson DW
Kidney Int; 2016 Jun; 89(6):1337-45. PubMed ID: 27165824
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes of patients with end-stage kidney disease due to membranoproliferative glomerulonephritis: an ANZDATA registry study.
Wilson GJ; Cho Y; Teixiera-Pinto A; Isbel N; Campbell S; Hawley C; Johnson DW
BMC Nephrol; 2019 Nov; 20(1):417. PubMed ID: 31752734
[TBL] [Abstract][Full Text] [Related]
8. Outcome of renal transplantation in patients with pauci-immune small vessel vasculitis or anti-GBM disease.
Deegens JK; Artz MA; Hoitsma AJ; Wetzels JF
Clin Nephrol; 2003 Jan; 59(1):1-9. PubMed ID: 12572924
[TBL] [Abstract][Full Text] [Related]
9. Duration of end-stage renal disease and kidney transplant outcome.
Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK
Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892
[TBL] [Abstract][Full Text] [Related]
10. The outcomes of patients with ESRD and ANCA-associated vasculitis in Australia and New Zealand.
Tang W; Bose B; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Clayton PA; Campbell SB; Peh CA; Johnson DW
Clin J Am Soc Nephrol; 2013 May; 8(5):773-80. PubMed ID: 23349331
[TBL] [Abstract][Full Text] [Related]
11. End-stage kidney disease due to Alport syndrome: outcomes in 296 consecutive Australia and New Zealand Dialysis and Transplant Registry cases.
Mallett A; Tang W; Clayton PA; Stevenson S; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Campbell SB; Johnson DW
Nephrol Dial Transplant; 2014 Dec; 29(12):2277-86. PubMed ID: 25061124
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes of patients with end-stage kidney disease due to membranous nephropathy: A cohort study using the Australia and New Zealand Dialysis and Transplant Registry.
Yang WL; Bose B; Zhang L; Mcstea M; Cho Y; Fahim M; Hawley CM; Pascoe EM; Johnson DW
PLoS One; 2019; 14(8):e0221531. PubMed ID: 31442267
[TBL] [Abstract][Full Text] [Related]
13. [REIN Report 2011--summary].
Couchoud C; Lassalle M; Jacquelinet C
Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
[TBL] [Abstract][Full Text] [Related]
14. Kidney transplant outcomes in patients with Fabry disease.
Shah T; Gill J; Malhotra N; Takemoto SK; Bunnapradist S
Transplantation; 2009 Jan; 87(2):280-5. PubMed ID: 19155985
[TBL] [Abstract][Full Text] [Related]
15. ESRD in Australia and New Zealand at the end of the millennium: a report from the ANZDATA registry.
McDonald SP; Russ GR; Kerr PG; Collins JF;
Am J Kidney Dis; 2002 Dec; 40(6):1122-31. PubMed ID: 12460029
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression.
Levy JB; Turner AN; Rees AJ; Pusey CD
Ann Intern Med; 2001 Jun; 134(11):1033-42. PubMed ID: 11388816
[TBL] [Abstract][Full Text] [Related]
17. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
[TBL] [Abstract][Full Text] [Related]
18. Survival of patients with ANCA-associated vasculitis on chronic dialysis: data from the French REIN registry from 2002 to 2011.
Romeu M; Couchoud C; Delarozière JC; Burtey S; Chiche L; Harlé JR; Gondouin B; Brunet P; Berland Y; Jourde-Chiche N
QJM; 2014 Jul; 107(7):545-55. PubMed ID: 24570478
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and Outcomes of Granulomatosis With Polyangiitis (Wegener) and Microscopic Polyangiitis Requiring Renal Replacement Therapy: Results From the European Renal Association-European Dialysis and Transplant Association Registry.
Hruskova Z; Stel VS; Jayne D; Aasarød K; De Meester J; Ekstrand A; Eller K; Heaf JG; Hoitsma A; Martos Jimenéz C; Ravani P; Wanner C; Tesar V; Jager KJ
Am J Kidney Dis; 2015 Oct; 66(4):613-20. PubMed ID: 25975963
[TBL] [Abstract][Full Text] [Related]
20. Effect of previously failed kidney transplantation on peritoneal dialysis outcomes in the Australian and New Zealand patient populations.
Badve SV; Hawley CM; McDonald SP; Mudge DW; Rosman JB; Brown FG; Johnson DW;
Nephrol Dial Transplant; 2006 Mar; 21(3):776-83. PubMed ID: 16280374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
